Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (61-70 of 494) with videos related to

Pageof 50
Sort By:
Plos One|October 11, 2012
Immunoexpression analysis and prognostic value of BLCAP in breast cancerIrina Gromova, Pavel Gromov, Niels Kroman, et al.
Diagnostic Pathology|July 26, 2015
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancerNathaniel Melling, Johanna Muth, Ronald Simon, et al.
International Journal of Cancer|October 16, 2012
RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinomaPierre Tennstedt, Robert Fresow, Ronald Simon, et al.
The Journal of Trauma|August 12, 2009
U.S. surgeon and medical student attitudes toward organ donationMark J Hobeika, Ronald Simon, Rajesh Malik, et al.
The Prostate|March 11, 2009
Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosisAchim Fleischmann, Thorsten Schlomm, Jens Köllermann, et al.
Plos One|October 25, 2011
No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern EuropeKristin Stieler, Sarah Schindler, Thorsten Schlomm, et al.
International Journal of Colorectal Disease|December 16, 2019
High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancerAndreas H Marx, Claudius Mickler, Guido Sauter, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 19, 2004
Expression and amplification of therapeutic target genes in retinoblastomaDoris Bösch, Mona Pache, Ronald Simon, et al.
Pathology Oncology Research : POR|June 1, 2015
Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue MicroarraysPhillip R Stahl, Jessica Schnellert, Christina Koop, et al.
Journal of Cancer Research and Clinical Oncology|January 23, 2025
Stromal PDGFR-beta expression is a prognostic factor in high-grade serous ovarian cancer patients but is it also predictive for response to antiangiogenic treatment?Annabelle Volk, Charlotte von Bülow, Aysche Stern, et al.
Pageof 50

Showing results (61-70 of 494) with videos related to

Sort By:
Pageof 50
Plos One|October 11, 2012
Immunoexpression analysis and prognostic value of BLCAP in breast cancerIrina Gromova, Pavel Gromov, Niels Kroman, et al.
Diagnostic Pathology|July 26, 2015
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancerNathaniel Melling, Johanna Muth, Ronald Simon, et al.
International Journal of Cancer|October 16, 2012
RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinomaPierre Tennstedt, Robert Fresow, Ronald Simon, et al.
The Journal of Trauma|August 12, 2009
U.S. surgeon and medical student attitudes toward organ donationMark J Hobeika, Ronald Simon, Rajesh Malik, et al.
The Prostate|March 11, 2009
Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosisAchim Fleischmann, Thorsten Schlomm, Jens Köllermann, et al.
Plos One|October 25, 2011
No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern EuropeKristin Stieler, Sarah Schindler, Thorsten Schlomm, et al.
International Journal of Colorectal Disease|December 16, 2019
High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancerAndreas H Marx, Claudius Mickler, Guido Sauter, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 19, 2004
Expression and amplification of therapeutic target genes in retinoblastomaDoris Bösch, Mona Pache, Ronald Simon, et al.
Pathology Oncology Research : POR|June 1, 2015
Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue MicroarraysPhillip R Stahl, Jessica Schnellert, Christina Koop, et al.
Journal of Cancer Research and Clinical Oncology|January 23, 2025
Stromal PDGFR-beta expression is a prognostic factor in high-grade serous ovarian cancer patients but is it also predictive for response to antiangiogenic treatment?Annabelle Volk, Charlotte von Bülow, Aysche Stern, et al.
Pageof 50